Fluicell AB (OSTO:FLUI) FFO per Share


OSTO:FLUI Fluicell AB OSTO:FLUI
50 GF Score
Price kr36.00
GF Value kr34.36
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fluicell AB FFO per Share?

FFO per Share only applies to REITs.

OSTO:FLUI
50GF Score
Fluicell AB OSTO:FLUI
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fluicell AB (OSTO:FLUI) Overvalued in 2026?

Based on GuruFocus' analysis, Fluicell AB stock appears to be overvalued. The current stock price of kr36.00 is trading 4.8% above its estimated GF Value™ of kr34.36. GuruFocus considers Fluicell AB to be Fairly Valued.

Key valuation signals for OSTO:FLUI:

  • FFO per Share:
  • GF Value™: kr34.36 vs. price of kr36.00 (4.8% above fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the OSTO:FLUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fluicell AB Business Description

Other Exchanges 5J90:Germany
Address Flojelbergsgatan 8C, Molndal, Gothenburg, SWE, 431 37
Fluicell AB is a Swedish life science company that conducts development in regenerative medicine and human tissue-based screening models for drug development, with a particular focus on the areas of type 1 diabetes, cardiac safety screening models, and kidney diseases. The company's platform for the production of human tissue that is based on Fluicell's technology for high-resolution 3D bioprinting, and which enables the creation of tissue-based products for use in drug development and regenerative medicine.
50GF Score

Get the complete analysis for OSTO:FLUI

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr36.00
Price
kr34.36
GF Value